Nucleosídeos

<p>2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is a nucleoside monophosphate that is chemically modified. It is a novel monomer that can be used in the synthesis of phosphoramidites, which are compounds used in the chemical modification of DNA or RNA. It has been shown to inhibit virus replication and activate antiviral responses in cells. 2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is also a high quality compound with a purity level of 99%.</p>

<p>5-Chloro-1-(b-D-arabinofuranosyl)cytidine is a monophosphate that is used as a precursor in the synthesis of antiviral and anticancer drugs. 5-Chloro-1-(b-D-arabinofuranosyl)cytidine is a synthetic nucleoside that can be activated by phosphorylation to form nucleosides and diphosphates, which are used in DNA synthesis. This drug also has anticancer properties, which have been demonstrated in animal models. It has been shown to inhibit the growth of leukemia cells by inhibiting the proliferation of cells in culture.</p>

<p>2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinofuranosyl)purine is a modified nucleoside. It is an antiviral agent that inhibits the replication of DNA by blocking the enzyme DNA polymerase. 2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D arabinofuranosyl)purine also has anticancer activity, which may be due to its ability to inhibit the synthesis of RNA and proteins in tumor cells. This compound is not commercially available but can be synthesized on request.</p>

<p>1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt is a novel anticancer and antiviral agent that belongs to the group of nucleosides. It has been shown in vitro to inhibit the growth of leukemia and lymphoma cells, as well as to reduce the production of HIV-1 RNA in infected cells. 1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt has also been shown to inhibit influenza virus replication at concentrations of 2x10 Molar. This drug is synthesized from deoxyribonucleoside phosphates, with modifications made to the ribonucleotide moiety. The synthesis of this compound requires an activator, which is a metal ion such as copper or zinc.</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is a novel nucleotide analogue that inhibits the growth of cancer cells by inhibiting DNA synthesis. It has been shown to be cytotoxic against leukemia, lymphoma, and breast cancer cells in vitro. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is also an antiviral agent and can inhibit HIV replication. This product is supplied as a white solid powder and is soluble in water.</p>

<p>N2-Isobutyryl-2'-(2-methoxyethyl)guanosine is a nucleoside that is structurally related to guanosine. It is used as an activator for RNA synthesis and as a novel antiviral agent. This compound has been shown to have high purity, high quality, and excellent solubility. N2-Isobutyryl-2'-(2-methoxyethyl)guanosine has also been found to be active against HIV in vitro by inhibiting reverse transcriptase activity.</p>

<p>5'-Deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is a novel, synthetic nucleoside phosphoramidite. It has been used as an anticancer and antiviral agent. The 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine monophosphate is an activator of DNA and RNA polymerases that are involved in the synthesis of DNA, RNA, and proteins. It has also been shown to inhibit viral replication by interfering with viral DNA synthesis. The chemical name for 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is 5-(Difluoromethoxy)-N4-[(4S)-4-(dimethylamino)butyl]-2',3'-dideoxycytidine monophosphate.</p>

<p>4-Chloro-5-methyl-7-(2-C-methyl-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a synthetic nucleoside analog that inhibits the viral DNA polymerase and prevents the synthesis of viral DNA. 4CMP 7MRP has antiviral, anticancer, and antiinflammatory activities. This compound is a phosphoramidite nucleoside with a novel scaffold structure that can be used in a variety of applications. It is also highly soluble in water and has high purity.</p>

<p>2'[3']-O-Acetyl-N6-benzoyl-5'-O-DMT-adenosine 3'[2]-O-succinate triethylamine salt is a phosphoramidite that can be used in the synthesis of oligonucleotides. It has antiviral activity and is an activator of ribonucleoside diphosphates. This product is novel and has not been previously described in any literature. The CAS number for this product is 68424-02-4.</p>

<p>Inosine-3',5'-cyclic-monophosphate sodium (cIMP) is a metabolite of inosine and is generated by the enzyme inosine monophosphate cyclohydrolase. cIMP has been shown to be related to colorectal adenocarcinoma, cancer, and body mass index. It has also been implicated in the diagnosis of cancer and infectious diseases. cIMP is involved in energy metabolism and DNA synthesis, which are important for the progression of renal cell cancer. In addition, it has been shown that cIMP can function as a biomarker for prognosis when used with multivariate logistic regression.</p>

<p>3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine is a synthetic antiviral agent that inhibits viral replication via the inhibition of viral DNA polymerase. The drug also has anticancer properties and is active against leukemia, breast cancer, and colon cancer cells. 3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine has been synthesized in a novel manner by the use of modified nucleosides and phosphoramidites. This compound has high purity and quality.</p>

<p>2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is a modified nucleoside with antiviral activity. It is an analog of deoxyinosine monophosphate that inhibits the growth of cells by inhibiting DNA synthesis. This compound has been shown to be effective against neoplastic cells and has been shown to inhibit the growth of human leukemic cells in vitro. The 2',3'-dideoxyinosine-5'-triphosphate trisodium salt is synthesized, purified, and characterized by high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR). 2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is chemically synthesized from 2',3'-dideoxyinosine monophosphate, which is reacted with sodium triphosphate in water to produce 2',3'-dideoxyinosine-5'-triph</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is a novel synthetic nucleoside with antiviral activity. It is phosphorylated to the corresponding monophosphate and diphosphate, which are then incorporated into DNA as deoxyribonucleosides. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is an activator of DNA polymerase η and κ.</p>

<p>5'-O-Acetyl-2'-deoxyuridine 3'-CE phosphoramidite is a novel nucleoside which is prepared by reacting 5'-O-acetyl-2'-deoxyuridine with bis(p-nitrophenyl)phosphoramidite. It has been shown to have antiviral and anticancer activities.</p>

<p>2'-O-Methylcytidine 5'-triphosphate lithium is a synthetic nucleotide</p>

<p>Biotin-16-deoxycytidine-5'-triphosphate, lithium salt is a synthetic nucleoside analogue that is an antiviral and anticancer drug. It is used to treat chronic hepatitis B virus infections. It is phosphorylated by adenosine kinase to form the corresponding 5'-triphosphate (Biotin-16-deoxycytidine-5'-triphosphate, lithium salt - 1 mM aqueous solution) which acts as an allosteric activator of RNA polymerase, which in turn increases the rate of rRNA synthesis. The compound has been shown to inhibit the growth of several cancer cell lines and increase apoptosis in some cells.</p>

<p>5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine is a synthetic nucleoside phosphoramidite. It is an activator of DNA synthesis and a substrate for the incorporation of ribonucleosides into DNA. 5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine is a novel, high purity, and high quality nucleotide. It has been used in anticancer research to treat leukemia and other cancers. 5'-O-DMT-2'-O-hexylphthalimido-5-methyluridine also inhibits viral replication by inhibiting the synthesis of viral DNA by binding to the 3' hydroxyl group of deoxyribonucleosides, such as thymidine.</p>

<p>5'-O-DMT-thymidine-3'-O-succinic acid (5'-DMT-TSA) is a novel modified nucleoside that is synthesized by the activation of 5'-DMT-thymidine with succinic anhydride. 5'-DMT-TSA has been shown to be a potent inhibitor of viral replication and has anti-tumor properties. This compound has high purity, high quality, and good solubility in water. It also has a CAS number of 74405-40-6.</p>

<p>N4-Benzoyl-1-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)cytosine is an antiviral compound that inhibits the synthesis of viral RNA. This nucleoside analog is a monophosphate and diphosphate inhibitor of ribonucleotide reductase, which is required for DNA and RNA synthesis. N4-Benzoylcytosine has also been shown to be cytotoxic against tumor cells in vitro and in vivo, making it a potential anticancer drug. It was synthesized as part of a novel series of compounds that have been shown to inhibit the growth of bacterial cultures, including Mycobacterium tuberculosis.</p>

<p>1-(2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl-b-L-arabinofuranosyl)-uracil is a phosphate derivative of uracil with antiviral, anticancer and nucleoside properties. It can be used as an activator for novel phosphoramidites and is synthetically modified from 2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl arabinofuranosyl uracil. This compound has high purity and high quality. 1-(2'-deoxy-2'-fluoro-3',5'-di-O-benzoyl arabinofuranosyl)-uracil is also a monophosphate derivative of uracil with antiviral, anticancer, and nucleoside properties. It can be used as an activator for novel phosphoramidites and is synthetically modified</p>

<p>2-Cyclohexyl-5-pyrimidinecarbaldehyde is a synthetic, modified nucleoside. It is an inhibitor of DNA synthesis and replication through its ability to inhibit the enzyme DNA polymerase. This compound has also shown antiviral activity by inhibiting the synthesis of viral RNA and inhibiting HIV-1 reverse transcriptase in vitro. 2-Cyclohexyl-5-pyrimidinecarbaldehyde is not active against cells that lack ribonucleotide reductase.</p>

<p>2'-Deoxy-5'-DMT-5-ethynyluridine 3'-CE phosphoramidite is a nucleoside that is used as an activator for DNA synthesis. It has been shown to be effective against viruses such as HIV and herpes simplex virus. This compound also has anticancer properties. 2'-Deoxy-5'-DMT-5-ethynyluridine 3'-CE phosphoramidite binds to the viral RNA or DNA, displacing the natural phosphate group on the 5' end of the viral chain and preventing viral replication.</p>

<p>8-Aminoadenosine-5'-triphosphate lithium salt - 100mM aqueous solution is an antiviral and anticancer agent that acts by inhibiting the synthesis of DNA. It also has been shown to be a novel activator of deoxyribonucleoside triphosphate (dNTP) activity. This product is used in biochemical research as a source of nucleosides, ribonucleosides, and phosphoramidites. It is also used in antisense therapy for the treatment of HIV infection.</p>

<p>3'-Deoxy-5'-O-DMT-thymidine 2'-CE phosphoramidite is a nucleoside analog that inhibits the growth of tumor cells by blocking DNA synthesis. It is a precursor to the active anticancer drug, 5-fluorouracil (5FU). 3'-Deoxy-5'-O-DMT-thymidine 2'-CE phosphoramidite can be used as an activator for the synthesis of other modified nucleotides. This synthetic compound has high purity and offers low cost for use in pharmaceuticals.</p>

<p>N6-Benzoyl-7-deaza-2'-deoxy-5'-O-DMT-7-iodoadenosine is a modified nucleoside that is used as an antiviral and anticancer agent. It inhibits the synthesis of DNA, RNA, and protein by inhibiting the activity of DNA polymerase and other enzymes. The drug also has high quality and purity properties, making it suitable for use in research projects.</p>

<p>2-Methanesulfonyl-4-phenyl-pyrimidine is a novel nucleoside phosphoramidite that is synthesized by the reaction of 2,4-dichlorophenyl pyrimidine with methanesulfonyl chloride and 3′-(dimethylamino)propylphosphine. It is a novel nucleoside phosphoramidite that reacts with the natural nucleosides to form their analogs. This product can be used as an antiviral agent or anticancer agent.</p>

<p>7-Chloro-3-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine is an active methylene compound that belongs to the group of tautomeric compounds. It is a pyrimidine derivative and a sodium salt of the amine. 7-Chloro-3-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine can be prepared from 2,4,6,-trichloropyrimidine by adding sodium hydride in dimethylformamide. This compound has been shown to be a nucleophile and an alkoxide in reactions with ketones and alcohols. 7CMTPD reacts with methylene groups in the presence of strong bases such as lithium diisopropylamide or potassium tert butoxide to form methylenetriazole derivatives.<br>7CMTPD can also react with nucleophiles</p>

<p>5-Fluoro-2'-o-methyl-4-(methylithio)uridine (5F-OMe-4MSU) is a novel anticancer drug that has been synthesized by modification of uridine. The 5F-OMe-4MSU was found to have high cytotoxicity against human cancer cell lines in vitro and in vivo, which may be due to its inhibition of ribonucleotide reductase. This drug also inhibits viral replication and can be used as an antiviral agent. 5F-OMe-4MSU is highly soluble in water and stable under acidic conditions, making it suitable for oral administration.</p>

<p>2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine is a synthetic nucleoside analog that inhibits viral DNA synthesis by acting as an inhibitor of the viral enzyme ribonucleotide reductase. 2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine has been shown to be effective against various viruses, including HIV and herpes simplex virus 1. This compound is also being studied as an anticancer agent due to its ability to inhibit cellular proliferation. 2-Chloro-4-[2-(4-fluorophenyl)ethyl]-6-methylpyrimidine is a phosphoramidite that can be used in the synthesis of modified nucleosides with novel antiviral or anticancer activity.</p>

<p>N6-benzoyl-2'-deoxy-5'-O-DMT adenosine-3'-Q Linker CPG 1000 Å is a novel nucleoside with antiviral activity. It is synthesized by the condensation of 2'-deoxyadenosine monophosphate and 3'-Q linker CPG 1000 Å. The molecular weight of N6-benzoyl-2'-deoxy-5'-O-DMT adenosine-3'-Q Linker CPG 1000 Å is 878.36 g/mol, and its CAS number is 628674-06-4. This substance has antiviral activity against herpes simplex virus type 1 (HSV1) and herpes simplex virus type 2 (HSV2). N6-benzoyl-2'-deoxy-5'-O-DMT adenosine can be used as an anticancer drug because it inhibits the growth</p>

<p>2'-Deoxy-a-uridine is a nucleoside that is used in the synthesis of DNA. It is one of the building blocks for the synthesis of RNA. 2'-Deoxy-a-uridine is an activator, which can phosphoramidate DNA and activate it to form new strands. This product can also be used as an antiviral agent and antineoplastic agent due to its inhibition of viral replication and cancer cell proliferation. It has been shown to bind to double-stranded DNA by intercalation, thereby preventing the strand from uncoiling and exposing a single strand for further binding by other agents. This product can also inhibit cell growth by inhibiting protein synthesis. 2'-Deoxy-a-uridine has been shown to have anticancer properties, including cytotoxic effects on leukemia cells in culture, as well as inducing apoptosis in tumor cells with low levels of p53 expression.<br>2'-Deoxy-a-uridine</p>

<p>4-(Isobutylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is a nucleoside analogue that inhibits viral replication by acting as an antiviral agent. It blocks the enzymatic activity of DNA polymerases, including reverse transcriptase, and prevents the synthesis of new viral DNA. 4-(Isobutylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is also an activator for HIV integrase, which is an enzyme that integrates HIV DNA into the host genome. This compound has been shown to be effective against HIV and herpes viruses in vitro.</p>

<p>2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer) is a synthetic nucleoside that acts as an antiviral, anticancer and antineoplastic agent. It has been shown to inhibit the replication of DNA and RNA by inhibiting the activity of ribonucleoides. 2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer) can be used in combination with other antiviral agents such as acyclovir or valacyclovir to treat herpes simplex virus type 1 infections. The drug is also effective against HIV, with a potency similar to that of zidovudine. It has been shown to be active in the treatment of leukemia, lymphoma, Hodgkin's disease and some solid tumors.</p>

<p>5-Bromo-2'-deoxyuridine 5'-diphosphate sodium salt - 10mM aqueous solution is a monophosphate nucleoside and an antiviral agent that inhibits viral DNA synthesis by inhibiting the activity of ribonucleotide reductase. The drug has been shown to be effective against herpes simplex virus, varicella zoster virus, and cytomegalovirus. It also has been shown to have anticancer activity in vitro and in vivo, which may be due to its ability to inhibit DNA synthesis.</p>

<p>4-Amino-3-benzyl-1H-pyrazolo[3,4-d]pyrimidine 1bDribofuranosyl 5'-triphosphate is a novel nucleoside analog that has been shown to have antiviral and anticancer activities. It acts as an activator of DNA polymerase, which results in the incorporation of deoxyribonucleotides into the growing DNA strand. This compound also inhibits DNA synthesis by competing with natural substrates for the enzyme ribonucleotide reductase. 4-Amino-3-benzyl-1H-pyrazolo[3,4-d]pyrimidine 1bDribofuranosyl 5'-triphosphate is a modified nucleoside that has been synthesized by replacing the phosphate group with diphosphate group on the sugar moiety. The chemical name for this compound is 4-(2'-deoxy-β</p>

<p>5'-O-DMT-2-thiouridine is a synthetic nucleoside that can be used as an antiviral and anticancer drug. It is the first novel nucleoside with a ribonucleoside moiety, which was synthesized by modifying uridine with 2,4,6-trimethoxybenzoyl chloride. The synthesis of 5'-O-DMT-2-thiouridine has been patented in China (CN101115587B) and the United States (US8483384).</p>

<p>2'-Deoxy-2'-fluoro-5-methylcytidine 5'-monophosphate is a synthetic nucleoside analog with antiviral and anticancer activity. It is an analogue of cytidine, which is a component of DNA and RNA. 2'-Deoxy-2'-fluoro-5-methylcytidine 5'-monophosphate inhibits the synthesis of DNA by inhibiting the enzyme DNA polymerase in virus replication, which blocks the synthesis of viral proteins. This drug also inhibits the growth of cancer cells by interfering with their ability to proliferate.</p>

<p>2'-Deoxy-2'-fluoro-2-methoxy-b-D-arabinoadenosine (FMA) is an antiviral nucleoside that has been shown to inhibit the growth of human T lymphocytes, human hepatoma cells and mouse lymphoma L5178Y cells. It also inhibits the replication of HIV in vitro and has been shown to be effective against other viruses such as herpes simplex virus type 1 and 2, cytomegalovirus, Epstein Barr virus, varicella zoster virus and vaccinia. FMA is a phosphoramidite compound that can be used in DNA synthesis. It is also a monophosphate analog of arabinoadenosine that can be used as an activator of deoxyribonucleosides. This novel compound can be modified to synthesize diphosphates or phosphoramidites.</p>

<p>3'-O-tert-Butyldimethylsilyl-5'-O-DMT-uridine is a nucleoside that is modified with a tert-butyldimethylsilyl group at the 3' position. It is used as an activator for synthesizing oligonucleotides, ribonucleosides, and phosphoramidites. 3'-O-tert-Butyldimethylsilyl-5'-O-DMT-uridine has antiviral and anticancer properties. This product can be used in research applications such as the synthesis of novel DNA and RNA molecules, as well as for diagnostic purposes such as detecting viral infections.</p>

<p>5'-O-DMT-N2-Dimethylformamid-2'-deoxy-2'-fluoroguanosine is a novel nucleotide analog with antiviral and anticancer properties. It is synthesized by reacting 5'-O-DMT-N2,N1,N6-trimethoxybenzoylguanosine with 2',3'-dideoxyadenosine in the presence of N,N-dimethylaminopyridine to form 5'-O-DMT-N2,N1,N6-trimethoxybenzoylguanosine 2',3'-dideoxyadenosine. The antiviral activity of this compound has been demonstrated in vitro against HIV and herpes viruses.<br>5'-O-DMT-N2,N1,N6 -trimethoxybenzoylguanosine 2',3' -dideoxyadenosine also</p>

<p>2-Deoxy-3,5-di-O-toluoyl-a-D-ribofuranosyl cyanide is a novel anticancer agent that has been shown to have potent antiviral and antiproliferative properties. It is a phosphoramidite monophosphate with a CAS number of 313214-62-0. This compound can be used in the synthesis of DNA and nucleosides due to its high purity and quality. 2DOTC has been shown to inhibit the growth of human cancer cells by targeting their DNA replication machinery. The mechanism of action for this drug is not fully understood, but it is believed that it may modify the activation function of some proteins involved in cell division.</p>

<p>2'-O-tert-Butyldimethylsilyl-5'-O-trityluridine is a synthetic nucleoside that is used in the synthesis of DNA, RNA and other nucleosides. The 2'-O-tert-butyldimethylsilyl group makes this nucleoside stable to hydrolysis by phosphodiesterases, which are enzymes that break down nucleic acids. This product is also a novel monophosphate analog of uridine and can be used as an activator for oligonucleotide synthesis. It is highly pure and has been modified with a trityl group to increase its stability. The CAS number for this product is 117136-35-3.</p>

<p>N6-Benzoyl-2'-deoxy-5-O-DMT-adenosine 3'-phosphonate triethylammonium salt is a potent antiviral agent that has been shown to inhibit the replication of DNA. It is active against herpesviruses, including cytomegalovirus (CMV) and Epstein-Barr virus (EBV). The drug has also been shown to be effective in inhibiting the growth of human cancer cells. The structure of the molecule is novel and it inhibits viral replication by blocking the synthesis of dNTPs, which are needed for DNA replication. N6-Benzoyl-2'-deoxy-5-O-DMT adenosine 3'-phosphonate triethylammonium salt was found to be more effective than other nucleoside analogues at inhibiting EBV replication in vitro and in vivo.</p>

<p>Cholesteryl-TEG Phosphoramidite is a phosphoramidite that is used in the synthesis of DNA. It is also known as cholesterol-1,2,3,4,5-pentaethyleneglutamate phosphoramidite. Cholesteryl-TEG Phosphoramidite has been shown to have antiviral and anticancer activity. The novel properties of this compound make it an interesting candidate for further study. This chemical is synthesized by reacting cholesteryl chloride with triethylene glycol monophosphate. It is also a modified nucleoside that contains a deoxyribonucleoside and an activated ribonucleoside.</p>

<p>2'-Deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite is a synthetic nucleoside that has shown anticancer and antiviral properties. It was first synthesized in the early 1990s and it is structurally similar to adenosine monophosphate. The synthesis of this compound starts with 5-iodo-2'-deoxyuridine, which reacts with the 5'-O-dimethoxytrityl group to form 2'-deoxy-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite. This nucleoside is then reacted with a phosphate triester to form 2'-deoxy-5'-O-DMT-5-[3-(2,2,2,-trimethylpropanoyl)propyl]thymidylic acid diphosphate.</p>

<p>5-Amino-1-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)-imidazole-4-carbonitrile is a novel nucleoside analogue that inhibits the viral enzyme ribonucleotide reductase. It has antiviral activity against the herpes viruses, cytomegalovirus, and Epstein Barr virus. 5AADC has also been shown to inhibit DNA synthesis in tumor cells. This compound is currently undergoing clinical trials as an anticancer agent.</p>

<p>5-Chloro-5'-deoxy-5'-iodo-2',3'-O-isopropylideneuridine is a synthetic nucleoside analogue. It has been used as a research tool for studying the activity of the enzyme thymidine phosphorylase, which is involved in the regulation of DNA synthesis. 5-Chloro-5'-deoxy-5'-iodo-2',3'-O-isopropylideneuridine was synthesized by condensing 1,6-dichlorobenzene with 2,3,4,6-tetraiodopyrimidine in the presence of potassium carbonate and zinc chloride. The thermal analysis showed that this compound exhibits high enthalpy and low entropy values. This means that it decomposes into products at high temperatures and has a relatively low reactivity.</p>

<p>2'-O-tert-Butyldimethylsilyl-O4-(4-chlorophenyl)-5'-O-DMT-uridine 3'-CE-phosphoramidite is a nucleoside that is used in the synthesis of DNA. It is a novel synthetic nucleotide with antiviral and anticancer properties. The phosphoramidite has been modified to give it high purity, and the monophosphate form has been synthesized. This nucleotide is synthesized through the use of an Activator, which activates the 2' position of the sugar moiety on the 5' phosphate terminus. This product is of high quality due to its high purity and novel synthetic nature.</p>

<p>Ribonucleosides are a class of compounds that contain the nucleoside ribose and the phosphate group. Ribonuclesides are modified ribonucleosides that have been synthesized and modified to be more stable than standard ribonucleotide analogs. The compound 5-Trimethylstannyl-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil is a novel nucleoside that has been shown to have anticancer, antiviral, and antiinflammatory activities in vitro. It is also an activator for phosphoramidites, which are used to modify DNA or RNA molecules. This chemical is available at high purity and quality with CAS No. 213136-14-2.</p>

<p>2'-Deoxy-N2,N8-di-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite is a novel nucleoside that has shown anticancer activity. It is a modified deoxyribonucleoside with an N2,N8-di-DMF group attached to the 2' position of the ribose and a 5'-O-DMT group at the 8 position of the ribose. The compound binds to DNA and inhibits viral protein synthesis by preventing RNA polymerase from initiating transcription. It also inhibits bacterial DNA gyrase, which results in inhibition of bacterial DNA replication. This product is synthesized using high purity chemical reagents and yields a high quality product that is free of contaminants.</p>